Sources: The Washington Post
Georgia receives 43,200 doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford. 2021-07-10
Yemen begins their COVID-19 vaccination campaign using the vaccine produced by AstraZeneca and the University of Oxford. 2021-04-20
The Ghana Health Service says that over 700,000 people in the country has received their first dose of the AstraZeneca vaccine. 2021-04-12
Clinical trials for the vaccine produced by Oxford and AstraZeneca show that it is 79% effective against COVID-19. 2021-03-22
Italy invokes the European Union powers to block shipment of 250,700 doses of the Oxford–AstraZeneca vaccine to Australia amid escalations between the bloc and AstraZeneca. The European Commission endorses the move. 2021-03-4
AstraZeneca-Oxford developers say that their vaccine candidate is effective against the UK variant of SARS-CoV-2. 2021-02-5
Kyrgyzstan is expected to receive 504,000 doses of the Oxford-AstraZeneca vaccine in March. 2021-02-2
Chile's health regulator approves a vaccine developed by the University of Oxford and AstraZeneca for emergency use in the country. 2021-01-27
India approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca, becoming the third country in the world to do so after the United Kingdom and Argentina. 2021-01-1
Morocco is expected to acquire 65 million vaccine doses from AstraZeneca and Sinopharm. 2020-12-25